Navigation Links
Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration

ing to its pituitary receptor LHRH triggers the release of luteinizing hormone, a key factor for the regulation of reproductive function. Continuous administration of exogenous LHRH or its agonists such as triptorelin leads to a rapid desensitization of its pituitary receptor resulting in a paradoxical effect that translates into the suppression of gonadal steroids such as testosterone and estradiol. This chemically induced and reversible castration is of therapeutic benefit in the treatment of hormone sensitive tumours such as breast and prostate. Triptorelin is the active ingredient of Decapeptyl(R) and Diphereline(R) available as 1- and 3-month sustained release formulations registered for the treatment of advanced metastatic hormone-dependent prostate cancer.

About Ipsen

Ipsen is an innovation driven international specialty pharmaceutical group with over 20 products on the market and a total worldwide staff of nearly 4,000. The company's development strategy is based on a combination of products in targeted therapeutic areas (oncology, endocrinology and neuromuscular disorders) which are growth drivers, and primary care products which contribute significantly to its research financing. This strategy is also supported by an active policy of partnerships. The location of its four Research and Development centres (Paris, Boston, Barcelona, London) gives the Group a competitive edge in gaining access to leading university research teams and highly qualified personnel. In 2006, R&D expenditure was EUR 178.3 million, i.e. 20.7% of consolidated sales, which amounted to EUR 861.7 million while total revenues amounted to EUR 945.3 million (in IFRS). 700 people in R&D are dedicated to the discovery and development of innovative drugs for patient care. Ipsen's shares are traded on Segment A of Eurolist by Euronext(TM) (stock code: IPN, ISIN code: FR0010259150). Ipsen's shares are eligible to the "Systeme a Reglement Differe" ("SRD") and the Group is p
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:7/31/2014)... , July 31, 2014 genae, a global ... announced today the incorporation of genae UK in London ... has one of the largest medical device markets in the world. ... is projected to increase by a CAGR of 6.0% until 2017. ... to 9.5% of GDP. Despite recessionary pressures, market growth rates over ...
(Date:7/31/2014)... July 31, 2014 Vermillion, Inc. (NASDAQ: VRML), a ... will hold a conference call on Thursday, August 14, 2014, ... second quarter ended June 30, 2014. Financial results will be ... Vermillion,s Chairman, President and CEO James LaFrance ... period. Date: Thursday, August 14, 2014 Time: 4:30 ...
(Date:7/31/2014)... NEW YORK , July 31, 2014 ... developing better, faster and affordable treatments for tuberculosis (TB), ... Senior Vice President, Market Access. Ms. Robertson joins the ... the company,s business in Sub-Saharan Africa and ... will oversee the TB Alliance,s efforts to ensure beneficial ...
Breaking Medicine Technology:genae Opens Offices in London 2Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3
... 33% 3.5 Years Post Surgery, VIENNA, Va., May ... its cancer drug Multikine(R) was,shown to significantly increase ... of head and neck cancer patients. The data ... International Congress of,the International Association of Oral Oncology ...
... Compliance with Medication Instructions but,Underscore Need for ... Provider Efforts to Control Elevated,Blood Pressure, NEW ... of a survey,conducted by Harris Interactive(R) for ... the American Society of,Hypertension, Inc. (ASH) Twenty-Second ...
Cached Medicine Technology:CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 2CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 2Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 4Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 5Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 6Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 7
(Date:7/31/2014)... ARLINGTON HEIGHTS, Ill. (August 1, 2014) Women over ... health: an increased risk for obesity, greater struggles against ... outcomes. An article published in the August issue of ... scientific publication of the American College of Allergy, Asthma ... women in treating asthma, and offers practical solutions to ...
(Date:7/31/2014)... The 2013 PolyU TSI hit a record ... in 2012. The index measures inbound tourists’ satisfaction ... into an overall index. The 2013 index indicates ... Hong Kong over time. , The index shows ... in Hong Kong are attractions (79.27) and transportation ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Ce-Classes.com has ... education course for healthcare professionals, a Systematic Review ... upon material published in the International Journal of Clinical ... created in response to a need to have accurate ... provide the best treatment possible. The material provides ...
(Date:7/31/2014)... In today’s world, a good night’s sleep has ... sleep apnea (a medical problem where the airway collapses during ... of the rest they need to face their daily challenges. ... 20 million people in the United States alone have sleep ... and of those treated, many cannot tolerate their prescribed medical ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Weblify has finally ... 4 years of development and testing. The result is ... websites in as little as 5 minutes without knowing any ... Weblify review , Shane Michaels, an SEO expert, agrees that ... “I’ve seen a lot of web site builders out ...
Breaking Medicine News(10 mins):Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3
... self-esteem programs receive expansion ... ... recently,awarded $4 million in grants to two nonprofit organizations through its,Highmark ... activity program and a self-esteem initiative, both available,throughout Highmark,s service area., ...
... Despite Scare in ABC,s "Eli,Stone", WHITE PLAINS, N.Y., ... directors of the U.S. Centers for Disease Control,and Prevention ... childhood,vaccines by the suggestion in an upcoming episode of ... -- which is no longer,used in vaccines -- may ...
... But experts question results of small Polish study , , ... a clogged left main coronary artery appeared to give better ... But American experts cast some doubt on the clinical value ... the Medical University of Silesia, compared results of surgery versus ...
... also available in Spanish . The Spanish ... on that using the safety belt on the road can save ... use of such device in the front seats of cars, whereas ... With such a situation on the table, the paper Individual factors ...
... Naturopathic Doctor and Integrative Cancer Treatment Expert,Starts 4-Year ... and Human,Services Secretary Michael Leavitt has appointed Timothy ... the National Advisory Council for Complementary,and Alternative Medicine ... vice president of integrative medicine for Cancer Treatment,Centers ...
... Relationship with NBME and Announces ... Certification Program, TAMPA, Fla., Jan. 29 ... Physicians, Inc. (ABQAURP) is pleased to,announce the organization ... Medical Examiners(R) (NBME(SM)) to oversee and administer ABQAURP,s,professional ...
Cached Medicine News:Health News:The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations 2Health News:The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations 3Health News:Childhood Vaccines Save Lives, March Of Dimes Says 2Health News:Childhood Vaccines Save Lives, March Of Dimes Says 3Health News:Stents Slightly Better Than Bypass for Blocked Left Coronary Artery 2Health News:Stents Slightly Better Than Bypass for Blocked Left Coronary Artery 3Health News:Using the safety belt in the rear seats of the car reduces death risk by almost a half 2Health News:National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 3
... addition to Laserscopes family of multi-application laser ... from, 1064nm Nd:YAG and 532nm KTP, the ... aesthetic laser market by pushing the envelope ... the safety and reliability record of a ...
... a new, portable, light weight, high power ... cosmetic and plastic surgery, general surgery, ENT ... resurfacing, it is the smallest, yet among ... market. It provides an ideal treatment for ...
... Series, including the Ceralas D and ... soft-tissue applications in medical, dental, and ... water and hemoglobin, the 980 nm ... and provide a bloodless field for ...
... Venus-i™ Laser System is a new, portable, ... with applications in dermatology, cosmetic and plastic ... ideal laser for skin resurfacing, it is ... Erbium:YAG lasers on the market. It provides ...
Medicine Products: